ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

September 30, 2011

Guest Opinion: Long Island Study’s Value Now Rests In Its Repository

November 2, 2002

DCBDC Advisors Ok Training Grant Program In Clinical Oncology

February 22, 1991

National Cancer Survey Data Available Soon: NCI Will Invite Investigators to Prepare Analysis

August 23, 1974

ORI takes Over Misconduct Inquiry Of NSABP Officials

July 29, 1994

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997